Comparing the genomes of snakes with distinct coloration patterns pinpointed the genetic variants that contribute to these ...

New gene-editing tools – most notably the Nobel Prize-winning CRISPR-Cas9 – allow targeted tweaks to a crop’s genome, ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...

As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...

This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...